The Little Canada-based company develops medical technology, products and services that treat cardiac, neurological and chronic pain patients.
Delayed Price / Updated: /
|52 Week High||71.90|
|52 Week Low||46.90|
|Today's Range||70.15 - 68.79|
The U.S. government expressed satisfaction with changes at a St. Jude Medical Inc. factory it cited earlier for testing and record-keeping problems, the company said Wednesday, resolving an issue...
A Chinese market for medical technology used to be on the long list of lofty goals for devicemakers like Medtronic. Now U.S. med-tech firms are seeing double-digit growth as they partner with Chinese...
Morningstar analyst Bridget Weishaar wrote in her quarter-ending consumer cyclical report last week “the structural shift to e-commerce from traditional retail reached a critical inflection...
Ashley Seeklander has an interesting job as a microbiologist. Important work. Good company.But, when she thought about what else she might want to do with her career, medical technology kept grabbing...
St. Jude Medical Inc. has launched the U.S. clinical trial of its leadless pacemaker, the Nanostim, as it aims to win regulatory approval.The device is less than 10 percent the size of a conventional...
|Current year rank||34|
|Current year compensation||$2,934,295|
|Percent change of the CEO||-5.1|
The Little Canada-based company is beginning to enroll U.S. patients in a clinical study of its new spinal cord stimulation system, which delivers what it calls burst stimulation.
Minnesota Topics are a comprehensive collection of Star Tribune content on select people, places and companies.